News

Noxopharm Subsidiary Nyrada Announces Important Drug Discovery
AFR 30 August 2018 : Advances in Biotech - Lower cholesterol treatment breakthrough
Nyrada- key progress with cholesterol-lowering drug candidate
Nyrada, Inc. Newsletter 2. April 2018
Nyrada,Inc. Newsletter 1. Jan/Feb 2018
Noxopharm Closes $4M Capital Raising for its US Subsidiary, Nyrada,Inc.
Identification of NYX-104, a promising lead candidate for the treatment of stroke and other excitotoxicity- associated disorders.
US biotech to develop Australian science
  Subscribe to Email Alerts